Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach?

This study aimed to discuss the possible role of morcellation for a giant myoma in the minimal invasive approach. Current literature, including U.S. Food and Drug Administration guidelines, was reviewed. We found that safety of morcellation for a giant myoma is questionable. The risk and benefits of...

Descripción completa

Detalles Bibliográficos
Autores principales: Iavazzo, Christos, Gkegkes, Ioannis D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Menopause 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408321/
https://www.ncbi.nlm.nih.gov/pubmed/34463075
http://dx.doi.org/10.6118/jmm.21014
_version_ 1783746801792188416
author Iavazzo, Christos
Gkegkes, Ioannis D.
author_facet Iavazzo, Christos
Gkegkes, Ioannis D.
author_sort Iavazzo, Christos
collection PubMed
description This study aimed to discuss the possible role of morcellation for a giant myoma in the minimal invasive approach. Current literature, including U.S. Food and Drug Administration guidelines, was reviewed. We found that safety of morcellation for a giant myoma is questionable. The risk and benefits of morcellation as well as alternative treatment options should be discussed with each individual patient.
format Online
Article
Text
id pubmed-8408321
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Menopause
record_format MEDLINE/PubMed
spelling pubmed-84083212021-09-08 Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach? Iavazzo, Christos Gkegkes, Ioannis D. J Menopausal Med Brief Communication This study aimed to discuss the possible role of morcellation for a giant myoma in the minimal invasive approach. Current literature, including U.S. Food and Drug Administration guidelines, was reviewed. We found that safety of morcellation for a giant myoma is questionable. The risk and benefits of morcellation as well as alternative treatment options should be discussed with each individual patient. The Korean Society of Menopause 2021-08 2021-08-17 /pmc/articles/PMC8408321/ /pubmed/34463075 http://dx.doi.org/10.6118/jmm.21014 Text en Copyright © 2021 by The Korean Society of Menopause https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ).
spellingShingle Brief Communication
Iavazzo, Christos
Gkegkes, Ioannis D.
Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach?
title Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach?
title_full Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach?
title_fullStr Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach?
title_full_unstemmed Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach?
title_short Minimal Invasive Myomectomy with Morcellation for Giant Myoma: A Challenge or a Questionable Approach?
title_sort minimal invasive myomectomy with morcellation for giant myoma: a challenge or a questionable approach?
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408321/
https://www.ncbi.nlm.nih.gov/pubmed/34463075
http://dx.doi.org/10.6118/jmm.21014
work_keys_str_mv AT iavazzochristos minimalinvasivemyomectomywithmorcellationforgiantmyomaachallengeoraquestionableapproach
AT gkegkesioannisd minimalinvasivemyomectomywithmorcellationforgiantmyomaachallengeoraquestionableapproach

Ejemplares similares